Stay updated on Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial
Sign up to get notified when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.

Latest updates to the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new Revision: v3.4.2 was added to the History, while the funding-status notice and Revision: v3.4.1 entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide notice about government funding status was added and the revision updated to v3.4.1 on 2026-02-02, while the prior v3.4.0 revision was deleted on 2026-01-05.SummaryDifference0.6%

- Check28 days agoChange DetectedThe update introduces UI elements (Show glossary), color-highlights for changes, and revision metadata on the history page, which are cosmetic and do not modify study data or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check42 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4; no study data or page content changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check49 days agoChange DetectedA new history entry for Study Status was added on 2026-01-05 (reference date 2026-01-01, version 63). The entry dated 2025-12-04 was removed.SummaryDifference0.2%

- Check63 days agoChange DetectedThe version history now includes a new entry 'Revision: v3.3.3'. Entries for 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed.SummaryDifference0.1%

Stay in the know with updates to Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.